FMC Corporation reported a significant decline in financial performance for the second quarter of 2026, with revenues of $867.1 million, down 17% from $1,050.5 million in the same period last year. The decrease was attributed to lower volumes and pricing pressures, particularly in North America, where demand for core legacy products has weakened. The company's gross margin also fell to $342.1 million, a decrease of 16% year-over-year, while net loss attributable to FMC stockholders reached $186.6 million, compared to a net income of $66.7 million in the prior year.

The company's financial results reflect a broader trend of declining sales across all major regions, with North America experiencing a 22% drop, followed by Europe, Middle East, and Africa (EMEA) at 18%, and Asia at 20%. The decline in revenue was compounded by increased restructuring and other charges, which totaled $222.3 million for the quarter, primarily due to costs associated with the company's Project Foundation initiative aimed at optimizing its cost structure. This included non-cash asset write-offs and accelerated depreciation costs.

In terms of strategic developments, FMC announced a definitive agreement for a $400 million minority equity investment from the Tessenderlo Group, which will acquire approximately 20% of FMC's outstanding shares. The funds from this investment are intended to be used for debt reduction. Additionally, FMC has signed a licensing agreement with Corteva, Inc. for the supply of the active ingredient rimisoxafen, which included a $200 million upfront payment recognized as deferred revenue.

Operationally, FMC is navigating a challenging environment, with cash and cash equivalents decreasing to $476.6 million as of June 30, 2026, down from $584.5 million at the end of 2025. The company has also classified its India commercial business as held for sale, with an expected sale price of $252 million, which is anticipated to close in 2026. The carrying value of this business has been adjusted to $350 million, reflecting an impairment charge of $43.6 million. Looking ahead, FMC aims to strengthen its balance sheet through various strategic transactions and is focused on improving its operational efficiency amid ongoing market pressures.

About FMC CORP

FMC Corporation is a global agricultural sciences company specializing in crop protection solutions, including insecticides, herbicides, fungicides, and biologicals. It serves farmers worldwide by providing innovative, sustainable products that enhance crop yields and resilience. FMC leverages proprietary technologies, a strong innovation pipeline, and strategic acquisitions to maintain industry leadership and address agricultural challenges sustainably.

This description was generated via AI from an annual report. Updated about 1 year ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.

View the complete official filing on the SEC website.

Read on SEC.gov